Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Lonza Launches Large Scale Peptide Production - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Lonza Launches Large Scale Peptide Production

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Lonza, Basel, Switzerland, has set up cGMP manufacturing capacity for large-scale solid phase manufacture of peptides at its Visp, Switzerland, facility. The move will complement Lonza’s Biotec capabilities for cGMP manufacture of small molecule peptides by microbial fermentation. Lonza now offers peptides synthesis in solid phase (solid phase peptide synthesizers, 2-800 liters), in liquid phase and by microbial fermentation.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters